论文部分内容阅读
冠心病是中老年常见病、多发病。三参通脉口服液是用于治疗冠心病(属于中医胸痹心痛)气阴两虚,兼瘀血内阻证型的中成药。现将三参通脉口服液对冠心病患者的内皮素(ＥＴ)、降钙素基因相关肽(ＣＧＲＰ)的影响报告如下。资料和方法1 一般资料 选择住院患者共86例。全部病例均符
Coronary heart disease is a common and frequently-occurring disease in the elderly. Sanshen Tongmai Oral Liquid is a proprietary Chinese medicine used for the treatment of coronary heart disease (which belongs to traditional Chinese medicine chest pain), Qi and Yin deficiency, and blood stasis syndrome. The effects of Sanshen Tongmai Oral Liquid on endothelin (ET) and calcitonin gene-related peptide (CGRP) in patients with coronary heart disease are reported below. Materials and Methods 1 General Information A total of 86 inpatients were selected. All cases are full